Telomeres, p53 and cellular senescence

D Wynford-Thomas1

  • 1Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.

Oncology Research
|January 1, 1996
PubMed

Insights

Cellular aging (senescence) involves a biological clock linked to telomere shortening, which downregulates responses to growth signals. This review explores how tumor suppressor genes like p53 and pRb mediate cell cycle arrest during aging.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Cellular aging, or senescence, is characterized by a reduced ability of mammalian cells to respond to external growth signals (mitogens).
  • Telomere shortening acts as a biological clock, triggering lifespan checkpoints that lead to cell cycle arrest.
  • Tumor suppressor gene products, such as p53 and pRb, play crucial roles in these intrinsic inhibitory signal pathways.

Purpose of the Study:

  • To review the intrinsic inhibitory signal pathways linking telomere-based aging clocks to cell cycle arrest.
  • To focus on the roles of p53 and pRb proteins in cellular senescence.
  • To examine cell-type specific differences in lifespan checkpoints and their associated inhibitory pathways.

Main Methods:

  • Literature review of intrinsic inhibitory signal pathways.
  • Analysis of the roles of tumor suppressor gene products (p53, pRb) in cell cycle arrest.
  • Comparative analysis of cell-type specific differences in aging mechanisms.

Main Results:

  • Senescence downregulates cellular responses to mitogens, likely mediated by a telomere-dependent biological clock.
  • p53 and pRb proteins are central to the inhibitory pathways linking the aging clock to cell cycle arrest.
  • Diversity exists in the timing and choice of inhibitory pathways across different cell types.

Conclusions:

  • Cell-type specific variations in aging checkpoints and inhibitory pathways may explain differential selection of tumor suppressor gene mutations.
  • This diversity offers a novel perspective on the molecular pathology and clinical behavior differences observed in human breast cancer subtypes.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...